[miR-451 inhibits malignant progression of multiple myeloma RPMI-8226 cells by targeting c-Myc].

Lu, J; Men, L J; Li, T T; Sun, L; Wu, X F

Lu, J; Men, L J; Li, T T; Sun, L; Wu, X F.

Afiliação

Lu J; Department of Hematology, Jinan People's Hospital Affiliated to Shandong First Medical University, Jinan City People's Hospital, Jinan 271100, China.
Men LJ; Department of Hematology, Jinan People's Hospital Affiliated to Shandong First Medical University, Jinan City People's Hospital, Jinan 271100, China.
Li TT; Department of Hematology, Jinan People's Hospital Affiliated to Shandong First Medical University, Jinan City People's Hospital, Jinan 271100, China.
Sun L; Department of Hematology, Jinan People's Hospital Affiliated to Shandong First Medical University, Jinan City People's Hospital, Jinan 271100, China.
Wu XF; Department of Hematology, Jinan People's Hospital Affiliated to Shandong First Medical University, Jinan City People's Hospital, Jinan 271100, China.

Zhonghua Zhong Liu Za Zhi ; 42(7): 560-564, 2020 Jul 23.

Article em Zh | MEDLINE | ID: mdl-32842443

Assuntos

Proliferação de Células; MicroRNAs; Mieloma Múltiplo; Linhagem Celular Tumoral; Movimento Celular; Sobrevivência Celular; Regulação Neoplásica da Expressão Gênica; Genes myc; Humanos; MicroRNAs/genética; MicroRNAs/fisiologia; Mieloma Múltiplo/genética; Invasividade Neoplásica

Palavras-chave

Invasion; Migration; Multiple Myeloma; Proliferation; c-Myc; miR-451

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: MicroRNAs / Proliferação de Células / Mieloma Múltiplo Limite: Humans Idioma: Zh Revista: Zhonghua Zhong Liu Za Zhi Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google